Cannabis-associated hyperalgesia and reduced local anesthetic efficacy in oral surgery
#67
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians performing oral surgery need to recognize that chronic cannabis use may impair local anesthetic effectiveness and increase pain sensitivity, potentially requiring adjusted anesthetic protocols or doses. Patients with cannabis use disorder undergoing oral procedures should be counseled about potential complications and the need for alternative pain management strategies beyond standard local anesthesia. Understanding this cannabis-pain pathway interaction allows clinicians to anticipate complications, improve informed consent, and optimize perioperative care for this patient population.
# Clinical Summary
This article describes an atypical adverse effect observed in oral surgery patients: cannabis use is associated with heightened pain sensitivity and diminished response to local anesthetics during dental procedures. The proposed mechanism involves chronic cannabinoid-induced alterations in endogenous pain modulation pathways, leading to a state of hyperalgesia where patients experience exaggerated pain despite adequate anesthetic administration. This finding has direct implications for perioperative management, as standard local anesthetic dosing and techniques may prove insufficient in regular cannabis users, potentially compromising surgical outcomes and patient satisfaction. Clinicians performing oral surgery or other procedures should consider cannabis use history when assessing anesthetic requirements and may need to employ adjusted anesthetic strategies for these patients. Understanding cannabis-associated hyperalgesia is particularly relevant as cannabis legalization increases the prevalence of regular users presenting for surgical care, making this a practical consideration for perioperative planning and patient counseling.
“We’re seeing some intriguing signals in the literature about cannabis and pain processing that deserve our attention in clinical practice, but I want to be direct: most of this evidence comes from case reports and mechanistic studies rather than large controlled trials in humans, so we need to remain appropriately cautious before drawing firm conclusions about how cannabis affects anesthetic response in our patients.”
🦷 Cannabis use may impair local anesthetic effectiveness and paradoxically lower pain thresholds in oral surgery patients, potentially complicating perioperative pain management. This cannabis-associated hyperalgesia likely results from chronic alterations in endocannabinoid signaling and pain modulation pathways, though the precise mechanisms remain incompletely understood and may vary based on frequency of use, cannabinoid composition, and individual genetic factors. Clinicians should recognize that cannabis-using patients may require higher anesthetic doses, more frequent redosing, or alternative pain management strategies, while acknowledging that some patients may underreport cannabis use due to lingering stigma or legal concerns. When obtaining anesthesia and pain histories prior to oral surgery, explicitly asking about cannabis use patterns and timing can help anticipate these challenges and allow for individualized anesthetic planning. Consider documenting cannabis use in the medical record and discussing realistic pain expectations with affected patients to
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:

